About my Start-up
Fideliomed operates in the diagnostics space, developing a point-of-care proprietary technology and a digital health platform to diagnose and monitor iron deficiency anemia in outpatients. Iron deficiency anemia is a silent, underdiagnosed pandemic. One in four people waiting in a doctor’s room suffer from anemia and/or iron deficiency; women (young women, pregnant women, women athletes, children under 5, patients with heart and kidney diseases) are at high risk for iron deficiency, anemia, and complications. We provide doctors’ offices and pharmacists with the first easy-to-use, multimarker test for quick diagnosis. Real-time diagnosis during the medical examination or as a service at pharmacy clinics would allow rapid treatment, avoiding diagnostic errors and costs related to the progression of the disease.
We provide doctors and pharmacists with the first easy-to-use and cost-effective multimarker test, combined with digital tools for quick and accurate diagnosis and monitoring in outpatients. Our product is a diagnostic device (reader device and single-use cartridge platform) based on our proprietary technology combined with digital assistance (professional web-app). The prototype is ready and the industrial phase is in progress, with market entry by q3 2024.
Now is the right time to bring into the market more decentralized healthcare solutions; there is an enormous need for new technologies and services to facilitate effective diagnostics in primary care, simplifying procedures, and alleviating health burdens.
We will follow a B2B business model; doctor’s offices and pharmacy chains will be our target sites, based on country-specific marketing strategies and with a razor blade revenue model.
The iron deficiency and anemia diagnostics market is a 3B$ market. We are seeking for 2M€ in Seed financing. Value-driving milestones are achievable within 18 month: Regulatory approval, MVP digital platform and pivot market test. Projected time to revenue within 2-3years
Why your idea is a “winner"?:
Now is the right time to bring into the market more decentralized healthcare solutions; there is an enormous need for new technologies and services to facilitate effective diagnostics in primary care, simplifying procedures, alleviating health burdens. Fideliomed will benefit from the combination of emerging technologies in more and more exciting areas: femtech, point-of-care testing, and digital health.
What is your current or intended business/revenue model?:
B2B
REVENUE MODEL: RAZOR BLADE MODEL
OUR TARGET SITES:
- GPs and internal specialists practices
- OB/GYN Practices
- Hematology/oncology practices
- Pediatric practices
- Urgent Care Centers (USA)
- Pharmacy Based Clinics (USA)
- Supermarket based clinics (USA)
- Pharmacy chains (EU)
Two economic keys to driving adoption in the US are covered:
-current reimbursement under existing codes
-a profitable level of reimbursement for the healthcare facility.
Do you have any Patent or IP registered (related to the solution that you are looking for an investment)?:
4 families patents, covering several key aspects of our technology
Has your technology already been implemented in any field/sector?:
Our diagnostic technology has been implemented to test several analytes in several biological samples (blood, urine, sweat)
Which market and customer need(s)/problem(s) is (are) your products(s)/service(s) going to solve?:
Iron deficiency anemia is a silent, underdiagnosed pandemic. On average it takes two medical visits and several months for the right diagnosis: physicians in primary care often miss it. Problems:
- LACK OF RAPID,ACCURATE POINT OF CARE DIAGNOSTIC TOOLS SPECIFIC FOR THE PRIMARY CARE;
- LACK OF EASILY ACCESSIBLE TOOLS FOR MONITORING TREATEMENT AND FOR RECURRENCE
Share
Facebook
Twitter
LinkedIn
Telegram
Tumblr
WhatsApp
VK
Mail